Skip to Main Content

Paper Details

A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer.
Cancer Cell
123
2013
Author NameAffiliation
William MatsuiThe Johns Hopkins University
Kylie J WaltersUniversity of Minnesota, Center for Cancer Research, National Cancer Institute
  • 1 - 2

Datasets

Release 1.2